Featured Research

from universities, journals, and other organizations

Method for diagnosis, prognosis of melanoma -- most aggressive skin cancer -- is patented

Date:
February 19, 2014
Source:
Elhuyar Fundazioa
Summary:
A method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate has been developed and recently patented. This method will help not only in the more effective early detection of this cancer, but also in the development of more personalized treatments. Melanoma is a malignant tumor resulting from the transformation of melanocytes, the cells that undertake to synthesize melanin, which protects us from the negative effects of solar radiation. Although melanoma is the least common among skin cancers, it is the one with the highest mortality rate, largely because of its high potential for metastasis.

Primary culture of human melanocytes.
Credit: Image courtesy of Elhuyar Fundazioa

UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection of this cancer, but also in the development of more personalized treatments.

Related Articles


Melanoma is a malignant tumor resulting from the transformation of melanocytes, the cells that undertake to synthesize melanin, which protects us from the negative effects of solar radiation. Although melanoma is the least common among skin cancers, it is the one with the highest mortality rate, largely because of its high potential for metastasis.

That is why "early diagnosis is the best tool we have to date for saving patients.In fact, patients with early-stage melanoma have a survival rate of 95%, while5-year survival falls to 50% in patients with metastasis," explained Yoana Arroyo, researcher in the UPV/EHU's department of Cell Biology and Histology, where this research was carried out.

The "Tumor Markers and New Therapies" research group of the Department of Cell Biology and Histology has been working in the field of cutaneous melanoma for many years.Its work seeks to identify a set of markers that can be used in the diagnosis and/or prognosis of malignant melanoma or which are responsible for susceptibility."Our strategy began because we were looking for proteins whose expression might be altered in melanoma cells in comparison with normal melanocytes, and on the basis of that result we have been looking into the corresponding genes by studying their expression, mutations and epigenetics," pointed out Dr Arroyo.

The results confirmed that melanoma cells display characteristic patterns of gene and protein expression;these make it possible to distinguish between tumor and non-tumor status,and within tumor status, too, it is possible to pick out those cells with an invasive capacity and therefore more likely to lead to the onset of metastasis. So the researchers have identified new molecular biomarkers that are relevant in melanoma diagnosis, prognosis and susceptibility.

The quest for more personalized treatments

Right now, the UPV/EHU researchers are in the phase involving the validation of candidate genes by analyzing their expression levels in biopsies of melanoma and nevi (growths of non-malignant melanocytes). The biopsies come from patients diagnosed at the University Hospitals of Cruces and Basurto.The aim is "to find a combination of molecular markers that will enable us to come up with the diagnosis and prognosis of the melanoma in the most effective way possible."

"This diagnosis method is a way of identifying those patients who are more likely to develop metastasis, so that their treatment and survival can be improved.This study could also open up new avenues of research for the development of new, more personalized treatments," explained Dr Arroyo.


Story Source:

The above story is based on materials provided by Elhuyar Fundazioa. Note: Materials may be edited for content and length.


Cite This Page:

Elhuyar Fundazioa. "Method for diagnosis, prognosis of melanoma -- most aggressive skin cancer -- is patented." ScienceDaily. ScienceDaily, 19 February 2014. <www.sciencedaily.com/releases/2014/02/140219075439.htm>.
Elhuyar Fundazioa. (2014, February 19). Method for diagnosis, prognosis of melanoma -- most aggressive skin cancer -- is patented. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2014/02/140219075439.htm
Elhuyar Fundazioa. "Method for diagnosis, prognosis of melanoma -- most aggressive skin cancer -- is patented." ScienceDaily. www.sciencedaily.com/releases/2014/02/140219075439.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins